Brief: Creo Medical Group Says Will Achieve 2024 Objectives For Core Revenue
15/05/2024 07:31
May 15 (Reuters) - Creo Medical Group PLC CREO.L :
* Q1-24 TRADING HAS BEEN IN-LINE WITH EXPECTATIONS
* GROUP REMAINS ON TRACK FOR H1-24 TARGETS
* TIGHT CONTROL ON COSTS HAS BEEN MAINTAINED
* GROUP WILL ACHIEVE ITS 2024 OBJECTIVES FOR CORE REVENUE
Source text for Eikon: ID:nRSO4464Oa
Further company coverage: CREO.L
((Reuters.Briefs@thomsonreuters.com;))